Search research articles
Contact Us
Filters
Showing results (101-110 of 151) with videos related to
Page
of 16
Sort By:
Bone Marrow Transplantation
|
October 9, 2007
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma
C Gisselbrecht, W Bethge, R F Duarte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte
M Diviné, E Lepage, J Brière, et al.
Blood
|
June 25, 1998
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)
C Gisselbrecht, P Gaulard, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2007
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2
P Morel, P Gaulard, C Gisselbrecht, et al.
Leukemia
|
October 26, 2002
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements
F Jardin, G Buchonnet, F Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol
P Brice, D Simon, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2013
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study
P L Zinzani, J M Vose, M S Czuczman, et al.
Hematology and Cell Therapy
|
April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemia
E Archimbaud, V Leblond, P Fenaux, et al.
Blood
|
September 10, 1998
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study
B Coiffier, C Haioun, N Ketterer, et al.
Genes, Chromosomes & Cancer
|
May 30, 2013
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma
P Bertrand, C Maingonnat, D Penther, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 151) with videos related to
Sort By:
Page
of 16
Bone Marrow Transplantation
|
October 9, 2007
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma
C Gisselbrecht, W Bethge, R F Duarte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte
M Diviné, E Lepage, J Brière, et al.
Blood
|
June 25, 1998
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)
C Gisselbrecht, P Gaulard, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2007
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2
P Morel, P Gaulard, C Gisselbrecht, et al.
Leukemia
|
October 26, 2002
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements
F Jardin, G Buchonnet, F Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol
P Brice, D Simon, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2013
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study
P L Zinzani, J M Vose, M S Czuczman, et al.
Hematology and Cell Therapy
|
April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemia
E Archimbaud, V Leblond, P Fenaux, et al.
Blood
|
September 10, 1998
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study
B Coiffier, C Haioun, N Ketterer, et al.
Genes, Chromosomes & Cancer
|
May 30, 2013
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma
P Bertrand, C Maingonnat, D Penther, et al.
Page
of 16